Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirogabalin in Asian patients with DPNP
NCT02318706Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirogabalin in diabetic polyneuropathy (DPN), sponsored by Daiichi Sankyo Co., Ltd.. Started Jan 2015; status: completed.
02
Drugs
mirogabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT02318706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02318706.